期刊文献+

Surgery for hepatocellular carcinoma with tumor thrombosis in inferior vena cava: A case report

下载PDF
导出
摘要 BACKGROUND Hepatocellular carcinoma(HCC)accompanied by a tumor thrombus is very common.However,the treatment strategy is controversial and varies by the location of the thrombus.CASE SUMMARY We report herein a case of HCC with a tumor thrombus in the suprahepatic inferior vena cava(IVC),which was successfully treated by hepatectomy combined with thrombectomy following sorafenib chemotherapy.A 47-year-old woman with chronic hepatitis was diagnosed with HCC.Computed tomography and magnetic resonance imaging showed that the tumor lesion was located in the right half of the liver,and a tumor thrombus was detected in the suprahepatic IVC near the right atrium.After multi-departmental discussion and patient informed consent,right major hepatectomy and total removal of the tumor thrombus were successfully performed under cardiopulmonary bypass.There were no serious complications after surgery.Following sorafenib treatment,no recurrence has been detected so far(11 mo later).CONCLUSION Surgical treatment followed by adjuvant sorafenib therapy might be an acceptable choice for HCC patients with tumor thrombosis in the IVC.
出处 《World Journal of Clinical Cases》 SCIE 2021年第36期11495-11503,共9页 世界临床病例杂志
基金 the National Natural Science Foundation of China,No.81802767 and No.81860117.
  • 相关文献

参考文献4

二级参考文献149

  • 1Di-Yang Xie,Zheng-Gang Ren,Jian Zhou,Jia Fan,Qiang Gao.2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights[J].Hepatobiliary Surgery and Nutrition,2020,9(4):452-463. 被引量:85
  • 2Cheng Zhou,Yuanfei Peng,Kaiqian Zhou,Lan Zhang,Xiangyu Zhang,Lei Yu,Jie Hu,Feiyu Chen,Shuangjian Qiu,Jian Zhou,Jia Fan,Zhenggang Ren,Zheng Wang.Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma[J].Hepatobiliary Surgery and Nutrition,2019,8(1):19-28. 被引量:27
  • 3Tianfu Wen,Chen Jin,Antonio Facciorusso,Matteo Donadon,Ho-Seong Han,Yilei Mao,Chaoliu Dai,Shuqun Cheng,Bixiang Zhang,Baogang Peng,Shunda Du,Changjun Jia,Feng Xu,Jie Shi,Juxian Sun,Peng Zhu,Satoshi Nara,JMichael Millis,Qiu Li,Weixia Chen,Wusheng Lu,Hong Tang,Lvnan Yan,Yong Zeng,Bo Li,Jiayin Yang,Wentao Wang,Hong Wu,Mingqing Xu,Zheyu Chen,Changli Lu,Chuan Li,Wei Peng,Xiaoyun Zhang.Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus[J].Hepatobiliary Surgery and Nutrition,2018,7(5):353-371. 被引量:41
  • 4Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet2012; 379: 1245-1255 [PMID: 22353262 DOI: 10.1016/S0140-6736(11)61347-0].
  • 5Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics,2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078 DOI:10.3322/canjclin.55.2.74].
  • 6Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer:worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16 [PMID: 15508102 DOI: 10.1053/j.gastro.2004.09.011].
  • 7European Association For The Study Of The Liver; EuropeanOrganisation For Research And Treatment Of Cancer. EASLEORTCclinical practice guidelines: management of hepatocellularcarcinoma. J Hepatol 2012; 56: 908-943 [PMID: 22424438 DOI:10.1016/j.jhep.2011.12.001].
  • 8Lencioni R. Chemoembolization in patients with hepatocellularcarcinoma. Liver Cancer 2012; 1: 41-50 [PMID: 24159570 DOI:10.1159/000339019].
  • 9Llovet JM, Bruix J. Systematic review of randomized trialsfor unresectable hepatocellular carcinoma: Chemoembolizationimproves survival. Hepatology 2003; 37: 429-442 [PMID:12540794].
  • 10Kim DY, Ryu HJ, Choi JY, Park JY, Lee DY, Kim BK, Kim SU,Ahn SH, Chon CY, Han KH. Radiological response predictssurvival following transarterial chemoembolisation in patients withunresectable hepatocellular carcinoma. Aliment Pharmacol Ther2012; 35: 1343-1350 [PMID: 22486716 DOI: 10.1111/j.1365-2036.2012.05089.x].

共引文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部